Content area
Full Text
* Context.-A strong independent association has been recently observed between elevated red blood cell distribution width (RDW) and increased incidence of cardiovascular events.
Objective.-To assess whether RDW is associated with plasma markers of inflammation since the mechanism(s) underlying this association remain unknown.
Design.-We retrospectively analyzed results of RDW, hemoglobin, mean corpuscular volume, ferritin, high-sensitivity C-reactive protein (hsCRP), and erythrocyte sedimentation rate (ESR) in a large cohort of unselected adult outpatients who were consecutively referred by general practitioners for routine medical check-up.
Results.-Cumulative results of RDW and other factors were retrieved from the database of our laboratory information system for 3845 adult outpatients during a 3-year period. When participants were grouped according to RDW quartiles, there were strong, graded increases of ESR and hsCRP (P < .001), both parameters being up to 3-fold higher in the fourth versus the first quartile. Accordingly, the percentages of those with hsCRP greater than 3 mg/L (from 28% to 63%; P < .001) and ESR greater than 40 mm/h (from 8% to 40%; P < .001) increased steadily across RDW quartiles. In multivariable regression analysis, ESR and hsCRP predicted RDW independently of age, sex, mean corpuscular volume, hemoglobin, and ferritin.
Conclusions.-To our knowledge, our study demonstrates for the first time a strong, graded association of RDW with hsCRP and ESR independent of numerous confounding factors. If confirmed in future follow-up studies, this association might provide a rationale to introduce the easy, inexpensive RDW in algorithms for cardiovascular risk prediction.
(Arch Pathol Lab Med. 2009;133:628-632)
Recent investigations of atherosclerosis have focused on inflammation, providing new insight into mechanisms of disease.1 In particular, current views regard atherosclerosis as a dynamic and progressive disease arising from the combination of endothelial dysfunction and in- flammation.2 Accumulating evidence suggests that circulating high-sensitivity C-reactive protein (hsCRP) represents one of the strongest predictors of cardiovascular morbidity and mortality in a number of settings. Indeed, hsCRP is currently the best validated inflammatory biomarker, since it appears to be a stronger predictor than total cholesterol, and it adds prognostic value to the Framingham risk score assessment.1,3 The link between hsCRP and atherosclerosis was initially suggested to be that of a biomarker versus a mediator of atherosclerosis. This dogma has been recently revisited, with observations from our group and...